CVS · Earnings call · 2026Q2T · Full report
Cash Flow and Liquidity
CVS HEALTH Corp · 2026-08-05 · Importance 92 · Surprise 84 · In source text
CVS generated approximately $10.6 billion of operating cash flow in the first half of 2026 from strong earnings and working-capital improvements. Management raised full-year operating cash flow guidance to at least $11.5 billion. Cash at the parent and unrestricted subsidiaries was approximately $2.7 billion at quarter end. The company reported a leverage ratio of approximately 3.5x and expects further improvement as it executes its 2026 outlook.
Key facts
- Updated full year expectation for cash flow from operations to at least $11.5 billion, an increase of $2 billion from prior guidance.
- Year-to-date cash flow from operations as of Q2 2026: approximately $10.6 billion.
- CVS does not assume any share repurchases in its current 2026 outlook and is only assuming offsetting dilution in long-term expectations and for 2027 at this point.
- Ended the quarter with approximately $2.7 billion of cash at the parent and unrestricted subsidiaries.
- Leverage ratio at quarter end: approximately 3.5x.
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| cash | positive | committed | +0.7% | Updated full year expectation for cash flow from operations to at least $11.5 billion, an increase of $2 billion from prior guidance. |
| cash | positive | realized | — | Year-to-date cash flow from operations as of Q2 2026: approximately $10.6 billion. |
| cash | positive | committed | — | CVS does not assume any share repurchases in its current 2026 outlook and is only assuming offsetting dilution in long-term expectations… |